CompletedNot Applicable

Hard and Soft Tissue Changes Following Immediate Implant Placement With Buccal Gap Management: Comparing the Use of Deproteinized Bovine Bone Mineral Socket Grafting and Sub-epithelial Connective Tissue Graft in a 6-month Pilot Study.

Lebanon8 participantsStarted 2025-01-02

Plain-language summary

This study aims to assess hard and soft tissue changes after immediate implant placement, comparing the use of a deproteinized bovine bone mineral and sub-epithelial connective tissue graft in the management of the buccal gap. This study involves clinical and radiographic evaluation to assess tissue changes following immediate implant placement. Preoperative procedures include a clinical diagnosis, clinical measurements, intraoral scanning, and CBCT analysis. After flap elevation, atraumatic extraction is performed followed by immediate implant placement. Buccal gap management is done using either a deproteinized bovine bone mineral or a connective tissue graft (placed on the flap). Postoperative assessments, including intraoral scans and CBCT imaging, are conducted at six months. To evaluate hard and soft tissue changes, the scans and CBCTs are superimposed using a digital software to quantify differences and statistical analysis is then performed

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (≥18 years of age) * Single hopless tooth in need for extraction in the maxillary or mandible area from second premolar to second premolar * Intact extraction socket; in the event of a potential facial fenestration, this should be no more than 3 mm apical from the marginal bone crest. * Buccal bone plate thickness ≥ 1.5 mm. * Sufficient apical bone to attain implant primary stability (a minimum of 35 N cm insertion torque) Exclusion Criteria: * \- Pregnant or lactating women * Patients with systemic diseases or inflammatory and autoimmune diseases affecting the oral cavity * Infected socket or periapical pathosis * History of radiotherapy or chemotherapy within the past 2 years * General contraindications for dental or surgical treatments * Uncontrolled diabetes * Concurrent or previous immunosuppressant, bisphosphonate, or high-dose corticosteroid therapy * Unable or unwilling to return for follow-up or comply with study procedures

What they're measuring

Change in vertical buccal bone height (mm) from baseline to 6 months

Timeframe: Baseline and 6 months

Trial details

NCT IDNCT07518823

SponsorSaint-Joseph University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-02